NAFLD, MAFLD and obesity: brothers in arms?

被引：25

作者：

Machado, Mariana Verdelho ^{[1
,2
]}

Cortez-Pinto, Helena ^{[1
]}

机构：

[1] Univ Lisbon, Fac Med, Clin Univ Gastrenterol, Lisbon, Portugal

[2] Hosp Vila Franca de Xira, Gastroenterol Dept, Lisbon, Portugal

来源：

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2023年 / 20卷 / 02期

关键词：

D O I：

10.1038/s41575-022-00717-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2022 was a proficuous year in both the nonalcoholic fatty liver disease (NAFLD) and obesity fields. Pharmacological treatment for obesity and NAFLD is moving forward, with the possibility of replacing bariatric surgery, artificial intelligence might help us access the histological effects of new drugs, and there were advances in personalized hepatocellular carcinoma screening in patients with NAFLD.

引用

页码：67 / 68

页数：2

共 10 条

[1]

[Anonymous], 2022, LANCET DIABETES ENDO, V10, P393

[2] Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease [J].

Fujiwara, Naoto ;

Kubota, Naoto ;

Crouchet, Emilie ;

Koneru, Bhuvaneswari ;

Marquez, Cesia A. ;

Jajoriya, Arun K. ;

Panda, Gayatri ;

Qian, Tongqi ;

Zhu, Shijia ;

Goossens, Nicolas ;

Wang, Xiaochen ;

Liang, Shuang ;

Zhong, Zhenyu ;

Lewis, Sara ;

Taouli, Bachir ;

Schwartz, Myron E. ;

Fiel, Maria Isabel ;

Singal, Amit G. ;

Marrero, Jorge A. ;

Fobar, Austin J. ;

Parikh, Neehar D. ;

Raman, Indu ;

Li, Quan-Zhen ;

Taguri, Masataka ;

Ono, Atsushi ;

Aikata, Hiroshi ;

Nakahara, Takashi ;

Nakagawa, Hayato ;

Matsushita, Yuki ;

Tateishi, Ryosuke ;

Koike, Kazuhiko ;

Kobayashi, Masahiro ;

Higashi, Takaaki ;

Nakagawa, Shigeki ;

Yamashita, Yo-ichi ;

Beppu, Toru ;

Baba, Hideo ;

Kumada, Hiromitsu ;

Chayama, Kazuaki ;

Baumert, Thomas F. ;

Hoshida, Yujin .

SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (650)

[3] Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes [J].

Hartman, Mark L. ;

Sanyal, Arun J. ;

Loomba, Rohit ;

Wilson, Jonathan M. ;

Nikooienejad, Amir ;

Bray, Ross ;

Karanikas, Chrisanthi A. ;

Duffin, Kevin L. ;

Robins, Deborah A. ;

Haupt, Axel .

DIABETES CARE, 2020, 43 (06) :1352-1355

[4] Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world [J].

Henry, Linda ;

Paik, James ;

Younossi, Zobair M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (06) :942-956

[5] Epidemiology and risk-stratification of NAFLD-associated HCC [J].

Ioannou, George N. .

JOURNAL OF HEPATOLOGY, 2021, 75 (06) :1476-1484

[6] Tirzepatide Once Weekly for the Treatment of Obesity [J].

Jastreboff, Ania M. ;

Aronne, Louis J. ;

Ahmad, Nadia N. ;

Wharton, Sean ;

Connery, Lisa ;

Alves, Breno ;

Kiyosue, Arihiro ;

Zhang, Shuyu ;

Liu, Bing ;

Bunck, Mathijs C. ;

Stefanski, Adam .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03) :205-216

[7] Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression [J].

Orci, Lorenzo A. ;

Sanduzzi-Zamparelli, Marco ;

Caballol, Berta ;

Sapena, Victor ;

Colucci, Nicola ;

Torres, Ferran ;

Bruix, Jordi ;

Reig, Maria ;

Toso, Christian .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) :283-+

[8]

Romero-Gómez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016

[9] Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective [J].

Soon, Gwyneth ;

Wee, Aileen .

CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) :44-57

[10] Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH [J].

V. Naoumov, Nikolai V. ;

Brees, Dominique ;

Loeffler, Juergen ;

Chng, Elaine ;

Ren, Yayun ;

Lopez, Patricia ;

Tai, Dean ;

Lamle, Sophie ;

Sanyal, Arun J. .

JOURNAL OF HEPATOLOGY, 2022, 77 (05) :1399-1409

← 1 →